Cargando…
Characterization of metabolic landscape in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the most prevalent cancers worldwide, accounting for approximately 75%-85% of primary liver cancers. Metabolic alterations have been labeled as an emerging hallmark of tumors. Specially, the last decades have registered a significant improvement in our unders...
Autores principales: | Wu, Jing, Xue, Ran, Jiang, Rong-Tao, Meng, Qing-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465443/ https://www.ncbi.nlm.nih.gov/pubmed/34616519 http://dx.doi.org/10.4251/wjgo.v13.i9.1144 |
Ejemplares similares
-
Prediction models for development of hepatocellular carcinoma in chronic hepatitis B patients
por: Guo, Jiang, et al.
Publicado: (2021) -
Immunotherapy for recurrent hepatocellular carcinoma
por: Bhatt, Ahan, et al.
Publicado: (2023) -
Apatinib as an alternative therapy for advanced hepatocellular carcinoma
por: Zhang, Xi-Hao, et al.
Publicado: (2020) -
Cooperative Instruction of Signaling and Metabolic Pathways on the Epigenetic Landscape
por: Kim, Jung-Ae
Publicado: (2018) -
Research progress regarding programmed cell death 1/programmed cell death ligand 1 inhibitors combined with targeted therapy for treating hepatocellular carcinoma
por: Zheng, Lin-Lin, et al.
Publicado: (2021)